Year: 2025

Rapala VMC Corporation, Stock Exchange Release, November 19, 2025 at 09:15 p.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Rapala VMC Corporation (“Rapala VMC”) issues hybrid capital securities in the aggregate amount of EUR 25 million (the “Capital Securities”). The Capital Securities bear a fixed coupon interest of 9.000 per cent per annum until November 27, 2028 (the “Reset Date”) and, from the Reset Date, a floating interest rate as defined in the terms and conditions of the Capital Securities. The Capital Securities do not have a specified maturity date, but Rapala VMC is entitled to redeem...

Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030Enables manufacturing of medicines across company’s main therapeutic areas in one geographic locationMarks latest milestone in company’s previously announced $23 billion investment in US infrastructureEast Hanover, November 19, 2025 – Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end manufacturing capabilities. The strategic investment is a major step to ensure all key Novartis medicines for US patients are manufactured in the US and delivered to patients across the country at scale. This announcement is part of Novartis’ $23 billion investment in US-based infrastructure over...

Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030Enables manufacturing of medicines across company’s main therapeutic areas in one geographic locationMarks latest milestone in company’s previously announced $23 billion investment in US infrastructureBasel, November 19, 2025 – Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end manufacturing capabilities. The strategic investment is a major step to ensure all key Novartis medicines for US patients are manufactured in the US and delivered to patients across the country at scale. This announcement is part of Novartis’ $23 billion investment in US-based infrastructure over the next...

TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (TSX: CNE) (OTCQX: CNNEF) (BVC: CNE.C) (“Canacol” or the “Company”) announces that the Company and its subsidiaries have obtained an initial order for creditor protection (the “Initial Order”) from the Court of King’s Bench of Alberta (the “Court”) pursuant to the Companies’ Creditors Arrangement Act (the “CCAA”). The order provides for a stay of proceedings for 10 days staying action by creditors and appointed KPMG Inc. as Court-appointed Monitor of the Company and its applicant subsidiaries (in such capacity, the “Monitor”). The CCAA is a Canadian federal statute that allows debtor companies to restructure their affairs under court supervision, with the aim of maximizing value for stakeholders and preserving business operations. Under the CCAA, the Company continues...

GF’s semiconductor technology, securely manufactured in the U.S., will be radiation-hardened by BAE Systems to withstand the harsh environment of space MALTA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) — GlobalFoundries (Nasdaq: GFS) (GF) today announced that BAE Systems will use GF’s advanced FinFET semiconductor technology in a new offering for space applications. Securely manufactured at GF’s facility in Malta, New York, this technology enables BAE Systems and others to create highly differentiated chips for electronic systems to withstand the harsh environment of space. With its new RH12™ Storefront, BAE Systems, using its intellectual property and design techniques, has created a turnkey solution to allow for the rapid development of custom radiation-hardened semiconductor solutions for space applications. These chips are...

MARSHALL, Texas, Nov. 19, 2025 (GLOBE NEWSWIRE) — Alpha Modus, Corp., a U.S.-based retail technology company and subsidiary of Alpha Modus Holdings, Inc. (NASDAQ: AMOD), today announced that it has filed a patent infringement lawsuit in the U.S. District Court for the Eastern District of Texas against Industria de Diseño Textil, S.A. (Inditex) and Zara USA, Inc. The lawsuit asserts infringement of U.S. Patent Nos. 11,042,890; 11,301,880; 12,026,731; and 12,354,121, which collectively protect Alpha Modus’s real-time retail analytics, personalized shopper engagement, inventory intelligence, and automated in-store purchase technologies. The complaint alleges that Zara’s retail environment, including its RFID garment tracking systems, digital surveillance technologies, mobile application features, and inventory replenishment platforms...